Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

Share Price Information for Gusbourne (GUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 59.50
High: 59.50
Low: 59.50
Prev. Close: 59.50
GUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

26 Jan 2006 08:00

GUS PLC26 January 2006 26 January 2006 GUS plc Acquisition of ClarityBlue by Experian GUS plc, the retail and business services group, today announces that Experianhas acquired ClarityBlue, a leading provider in the UK of bespoke marketingdatabase solutions for major companies. ClarityBlue complements Experian'sexisting marketing businesses which help clients to target, acquire and retaincustomers. The purchase price is £85m plus an earn-out of up to £15m over threeyears. This has been funded from GUS' existing bank facilities. Don Robert, Chief Executive Officer of Experian, commented: "ClarityBlue is highly complementary to Experian's marketing information andsolutions businesses. Its addition to our existing offer will better enable usto help our clients around the world to respond more rapidly and send customersthe right message, at the right time and over the right channel. We are veryexcited about the growth opportunities available to ClarityBlue which will befurther enhanced by becoming part of Experian." Description of ClarityBlue ClarityBlue designs, builds and manages marketing databases for large companieswith millions of customers. These customers can undertake multiple transactionswith the companies often on a daily basis and through different channels.ClarityBlue helps its clients to make better-informed decisions more quicklyabout how to target and acquire new customers and retain existing customers. Itworks for financial services providers, entertainment companies, mobile phoneoperators and Internet Service Providers. Its clients include Barclaycard,BSkyB, Morgan Stanley, O2 and Orange. Founded in 1999, ClarityBlue employs 165people, primarily in the UK. When developing marketing databases for its clients, ClarityBlue uses its ownunique technology platform and analytics to integrate data and software thatbest meet its clients' needs. In particular, it can link companies' existinginformation on customers with external data sources to create a complete pictureof customer behaviour. Its key competitive advantage is that its technologyplatform is very fast and flexible, speeding up decision-making and reducing thelead time for delivering marketing campaigns. This is all supported byClarityBlue's extensive board-level consulting expertise which helps to embed itat the heart of its clients' marketing strategies and processes. Rationale for acquisition ClarityBlue has a leading position in the marketing services industry in the UK,especially in sectors such as banking and telecommunications where speed ofresponse is critical. With sales up by 25% in the current year, ClarityBlue hasfurther strong organic growth opportunities, selling more to existing clientsand attracting new clients in a broad range of sectors including retail andtelecommunications. Experian expects to accelerate this growth. For example, ClarityBlue will beable to embed more easily Experian's existing marketing data and solutions, suchas demographic profiling, e-mail delivery and optimisation, in its offer toclients. In addition, the ClarityBlue technology platform complements Experian'sexisting offer in the US, opening up new markets such as serving mid-sizedcompanies, many of whom are already clients of Experian for other services. There will also be cost savings of several million pounds in areas such as dataprocessing, data purchasing and technology. In the year to July 2006, sales are expected to be about £30m (an increase ofover 25% year-on-year) with EBIT of about £5m. This excludes any expectedrevenue or cost synergies. Enquiries GUSDavid Tyler Group Finance Director 020 7495 0070Fay Dodds Director of Investor Relations FinsburyRupert Younger 020 7251 3801Rollo Head GUS announcements are available on www.gusplc.com. Certain statements made in this announcement are forward-looking statements.Such statements are based on current expectations and are subject to a number ofrisks and uncertainties that could cause actual events or results to differmaterially from any expected future events or results referred to in theseforward-looking statements. About ClarityBlue ClarityBlue, the customer intelligence specialist, designs, builds and operateshigh-performance customer data environments that link complex internal andexternal data sources to build a rich picture of customer behaviour. This isused to predict, and allows clients to manage, the future behaviour of itscustomers. ClarityBlue's key competitive advantage is that it does this atspeed, because of its powerful combination of strategic thinking, a configurabledirect marketing platform, precision analytics and exceptional processingcapability. For more information go to www.clarityblue.com. About Experian Marketing ClarityBlue will form part of Experian's Marketing Services division, a leadingprovider of direct marketing solutions in the UK, US and Continental Europe. Thedivision includes companies such as QAS, a leading address management softwaredeveloper, and CheetahMail, a leading provider of e-mail marketing and webanalytics solutions. The Marketing Services division provides a wide range ofsolutions that enable organisations to acquire and retain customers, improve thequality of customer data for marketing purposes and enhance the value ofcustomer relationships. For more information, visit www.experian.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.